Consumers urged to avoid unregulated Retatrutide products sold online

Products containing Retatrutide are currently being made available to consumers through unauthorised and unverified sources, predominantly on online platforms, social media, and through informal sellers. 

The products containing such medication are often promoted for weight loss purposes and other health-related benefits such as treating diabetes, but currently remain unregulated.

Consequently, such medications may be false, counterfeit, improperly stored, or of unknown origin or quality. 

The Superintendence of Public Health and the Malta Medicines Authority have alerted the public that this medication is not approved for public use and products containing it have not been authorised. 

Authorities are taking the necessary steps in order to identify, withdraw, and remove such products from the market.

The public is strongly urged to purchase medication solely from licensed pharmacies, and to exercise caution with products promoted through online channels and social media. 

Furthermore, it is also recommended to avoid substances marketed as being “experimental”, “research", or “not for human consumption”. 

Professional advice from licensed healthcare professionals, prior to using any medicine or health-related product, regardless of how it is advertised, is highly recommended. 

It is important to note that the use of unauthorised or unregulated products may pose serious risks, including adverse health effects, allergic reactions, contamination, toxicity, infections, and other potentially harmful consequences.

Healthcare professionals, retailers, and members of the public are encouraged to report any suspected unsafe, falsified, or illegal products through the appropriate reporting channels.